Biotech News
Tango Therapeutics Appoints Sung Lee to Board of Directors
ir.tangotx.com2026-05-06 15:29 EST
BOSTON, Jan. 05, 2026 (GLOBE NEWSWIRE) -- Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced the appointment of Mr. Sung Lee to the Board of Directors. Mr.